Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 3374

1.

Effects of work schedule and period of exposure on changes in urinary chromium and nickel excretion among rotating shift workers in a stainless-steel plant.

Itoh H, Wang RS, Maki S, Niu Q, Shang H, Su Y, Weng Z, Saito H, Miura N, Takahashi M.

Chronobiol Int. 2019 Aug 1:1-8. doi: 10.1080/07420528.2019.1645159. [Epub ahead of print]

PMID:
31368363
2.

Treatment preference for weekly versus daily DPP-4 inhibitors in patients with type 2 diabetes mellitus: outcomes from the TRINITY trial.

Meguro S, Matsui S, Itoh H.

Curr Med Res Opin. 2019 Aug 1:1. doi: 10.1080/03007995.2019.1651130. [Epub ahead of print]

PMID:
31366262
3.

Successful determination of nilotinib dosage by therapeutic drug monitoring in a patient with chronic myeloid leukemia developing hepatic dysfunction: A case report.

Nakahara R, Sumimoto T, Ogata M, Sato Y, Itoh H.

Clin Case Rep. 2019 Jun 14;7(7):1419-1421. doi: 10.1002/ccr3.2191. eCollection 2019 Jul.

4.

Association Between Acute Fall in Estimated Glomerular Filtration Rate After Treatment for Primary Aldosteronism and Long-Term Decline in Renal Function.

Kobayashi H, Abe M, Nakamura Y, Takahashi K, Fujita M, Takeda Y, Yoneda T, Kurihara I, Itoh H, Tsuiki M, Wada N, Ichijo T, Katabami T, Ogawa Y, Kawashima J, Yoshimoto T, Sone M, Inagaki N, Watanabe M, Kamemura K, Matsuda Y, Izawa S, Tanabe M, Tanabe A, Suzuki T, Naruse M; JPAS/JRAS Study Group.

Hypertension. 2019 Sep;74(3):630-638. doi: 10.1161/HYPERTENSIONAHA.119.13131. Epub 2019 Jul 22.

PMID:
31327258
5.

Renal impairment is closely associated with plasma aldosterone concentration in patients with primary aldosteronism.

Kawashima A, Sone M, Inagaki N, Takeda Y, Itoh H, Kurihara I, Umakoshi H, Ichijo T, Katabami T, Wada N, Ogawa Y, Kawashima J, Fujita M, Miyauchi S, Okamura S, Fukuoka T, Yanase T, Izawa S, Yoshikawa Y, Hashimoto S, Yamada M, Kai T, Suzuki T, Naruse M.

Eur J Endocrinol. 2019 Jul 1. pii: EJE-19-0047.R2. doi: 10.1530/EJE-19-0047. [Epub ahead of print]

PMID:
31319380
6.

Development of a high-throughput strategy for discovery of potent analogues of antibiotic lysocin E.

Itoh H, Tokumoto K, Kaji T, Paudel A, Panthee S, Hamamoto H, Sekimizu K, Inoue M.

Nat Commun. 2019 Jul 5;10(1):2992. doi: 10.1038/s41467-019-10754-4.

7.

Cost-Effectiveness of Cardiac Rehabilitation in Patients with Coronary Artery Disease: A Meta-Analysis.

Takura T, Ebata-Kogure N, Goto Y, Kohzuki M, Nagayama M, Oikawa K, Koyama T, Itoh H.

Cardiol Res Pract. 2019 Jun 4;2019:1840894. doi: 10.1155/2019/1840894. eCollection 2019. Review.

8.

Greeting Messages from President of Japanese Society of Hypertension (JSH) The challenge of JSH: moonshot for "Conquest of hypertension in Japan".

Itoh H.

Hypertens Res. 2019 Jul;42(7):925-927. doi: 10.1038/s41440-019-0279-6. Epub 2019 Jul 5. No abstract available.

PMID:
31273348
9.

National burden of the pharmaceutical cost of wet compresses and its cost predictors: nationwide cross-sectional study in Japan.

Itoh H, Saito T, Nojiri S, Hiratsuka Y, Yokoyama K.

Health Econ Rev. 2019 Jun 29;9(1):20. doi: 10.1186/s13561-019-0238-6.

PMID:
31256264
10.

Comparative genome-wide analysis of gastric adenocarcinomas with hyperplastic polyp components.

Takayama Y, Ono Y, Mizukami Y, Itoh H, Nakajima N, Arai H, Tanaka S, Nobusawa S, Yokoo H, Onozato Y.

Virchows Arch. 2019 Jun 28. doi: 10.1007/s00428-019-02592-y. [Epub ahead of print]

PMID:
31250201
11.

DNA Damage Repair and DNA Methylation in the Kidney.

Hayashi K, Hishikawa A, Itoh H.

Am J Nephrol. 2019;50(2):81-91. doi: 10.1159/000501356. Epub 2019 Jun 26. Review.

12.

Efficacy and safety of dosage-escalation of low-dosage esaxerenone added to a RAS inhibitor in hypertensive patients with type 2 diabetes and albuminuria: a single-arm, open-label study.

Itoh H, Ito S, Rakugi H, Okuda Y, Nishioka S.

Hypertens Res. 2019 Jun 25. doi: 10.1038/s41440-019-0270-2. [Epub ahead of print]

PMID:
31239535
13.

Population Pharmacokinetics and Pharmacodynamics of Apixaban Linking Its Plasma Concentration to Intrinsic Activated Coagulation Factor X Activity in Japanese Patients with Atrial Fibrillation.

Ueshima S, Hira D, Tomitsuka C, Nomura M, Kimura Y, Yamane T, Tabuchi Y, Ozawa T, Itoh H, Horie M, Terada T, Katsura T.

AAPS J. 2019 Jun 24;21(5):80. doi: 10.1208/s12248-019-0353-7.

PMID:
31236790
14.

Hypertension as a Metabolic Disorder and the Novel Role of the Gut.

Tanaka M, Itoh H.

Curr Hypertens Rep. 2019 Jun 24;21(8):63. doi: 10.1007/s11906-019-0964-5. Review.

15.

Full solid-phase total synthesis of macrocyclic natural peptides using four-dimensionally orthogonal protective groups.

Itoh H, Inoue M.

Org Biomol Chem. 2019 Jul 21;17(27):6519-6527. doi: 10.1039/c9ob01130g. Epub 2019 Jun 24.

PMID:
31232404
16.

Effect of Metabolically Healthy Obesity on the Development of Carotid Plaque in the General Population: A Community-Based Cohort Study.

Itoh H, Kaneko H, Kiriyama H, Yoshida Y, Nakanishi K, Mizuno Y, Daimon M, Morita H, Yatomi Y, Yamamichi N, Komuro I.

J Atheroscler Thromb. 2019 Jun 22. doi: 10.5551/jat.48728. [Epub ahead of print]

17.

Acute Interstitial Nephritis With Karyomegalic Epithelial Cells After Nivolumab Treatment-Two Case Reports.

Ryuzaki M, Tokuyama H, Uchiyama K, Nakaya H, Hasegawa K, Miyashita K, Konishi K, Hashiguchi A, Wakino S, Itoh H.

Clin Med Insights Case Rep. 2019 Jun 13;12:1179547619853647. doi: 10.1177/1179547619853647. eCollection 2019.

18.

Effect of cigarette smoking on carotid artery atherosclerosis: a community-based cohort study.

Kiriyama H, Kaneko H, Itoh H, Yoshida Y, Nakanishi K, Mizuno Y, Daimon M, Morita H, Yamamichi N, Komuro I.

Heart Vessels. 2019 Jun 20. doi: 10.1007/s00380-019-01455-5. [Epub ahead of print]

PMID:
31222551
19.

Comparison of performance characteristics between high-performance liquid chromatography and latex agglutination turbidimetric immunoassay for therapeutic drug monitoring of zonisamide.

Eto D, Tanaka R, Suzuki Y, Sato Y, Itoh H.

J Clin Lab Anal. 2019 Jun 20:e22940. doi: 10.1002/jcla.22940. [Epub ahead of print]

PMID:
31218755
20.

Left Main Coronary Artery Obstruction by Huge Noncoronary Cusp Calcification After Transcatheter Aortic Valve Replacement.

Kiriyama H, Kaneko H, Itoh H, Uehara M, Kodera S, Kiyosue A, Yamauchi H, Daimon M, Ando J, Morita H, Ono M, Komuro I.

JACC Cardiovasc Interv. 2019 Jul 8;12(13):1285-1287. doi: 10.1016/j.jcin.2019.01.243. Epub 2019 Jun 12. No abstract available.

PMID:
31202950
21.

Elevated bradykinin receptor type 1 expression in postpartum acute myometritis: Possible involvement in augmented interstitial edema of the atonic gravid uterus.

Shen Y, Oda T, Tamura N, Kohmura-Kobayashi Y, Furuta-Isomura N, Yaguchi C, Uchida T, Suzuki K, Itoh H, Kanayama N.

J Obstet Gynaecol Res. 2019 Aug;45(8):1553-1561. doi: 10.1111/jog.14012. Epub 2019 Jun 10.

PMID:
31179603
22.

Interstitial Lung Disease with Anti-melanoma Differentiation-associated Protein 5 Antibody: Rapidly Progressive Perilobular Opacity.

Chino H, Sekine A, Baba T, Kitamura H, Iwasawa T, Okudela K, Takemura T, Itoh H, Sato S, Suzuki Y, Ogura T.

Intern Med. 2019 Jun 7. doi: 10.2169/internalmedicine.2328-18. [Epub ahead of print]

23.

Intrauterine Fetal and Neonatal Death between Small for Date and Non-Small for Date in Small for Gestational Age Infants.

Itoh T, Matsuda Y, Itoh H, Ogawa M, Sasaki K, Kanayama N.

Int J Med Sci. 2019 Mar 9;16(4):501-506. doi: 10.7150/ijms.31153. eCollection 2019.

24.

Relation between the Updated Blood Pressure Classification according to the American College of Cardiology/American Heart Association Guidelines and Carotid Intima-Media Thickness.

Itoh H, Kaneko H, Kiriyama H, Yoshida Y, Nakanishi K, Mizuno Y, Daimon M, Morita H, Yatomi Y, Komuro I.

Am J Cardiol. 2019 Aug 1;124(3):396-401. doi: 10.1016/j.amjcard.2019.04.054. Epub 2019 May 9.

PMID:
31171318
25.

Burkholderia Gut Symbionts Associated with European and Japanese Populations of the Dock Bug Coreus marginatus (Coreoidea: Coreidae).

Ohbayashi T, Itoh H, Lachat J, Kikuchi Y, Mergaert P.

Microbes Environ. 2019 Jun 27;34(2):219-222. doi: 10.1264/jsme2.ME19011. Epub 2019 Jun 6.

26.

[Clinical Approach to Individualization of Antimicrobial Therapy Based on Pharmacokinetic/Pharmacodynamic Analysis and Therapeutic Drug Monitoring].

Sato Y, Suzuki Y, Tanaka R, Kaneko T, Itoh H.

Yakugaku Zasshi. 2019;139(6):917-922. doi: 10.1248/yakushi.18-00213-3. Review. Japanese.

27.

Vertical distribution of particle-associated and free-living ammonia-oxidizing archaea in Suruga Bay, a deep coastal embayment of Japan.

Ijichi M, Itoh H, Hamasaki K.

Arch Microbiol. 2019 May 30. doi: 10.1007/s00203-019-01680-6. [Epub ahead of print]

PMID:
31147749
28.

Efficacy and safety of esaxerenone (CS-3150) for the treatment of essential hypertension: a phase 2 randomized, placebo-controlled, double-blind study.

Ito S, Itoh H, Rakugi H, Okuda Y, Yamakawa S.

J Hum Hypertens. 2019 Jul;33(7):542-551. doi: 10.1038/s41371-019-0207-x. Epub 2019 May 21.

PMID:
31113987
29.

High-sensitivity simultaneous quantification of tacrolimus and 13-O-demethyl tacrolimus in human whole blood using ultra-performance liquid chromatography coupled to tandem mass spectrometry.

Ono H, Suzuki Y, Kaneko T, Tanaka R, Sato F, Sato Y, Mimata H, Itoh H.

Biomed Chromatogr. 2019 Sep;33(9):e4584. doi: 10.1002/bmc.4584. Epub 2019 Jun 6.

PMID:
31099107
30.

Draft Genome Sequence of Agarivorans sp. Strain Toyoura001, Isolated from an Abalone Gut.

Itoh H, Kawano K, Kihara M.

Microbiol Resour Announc. 2019 May 9;8(19). pii: e00169-19. doi: 10.1128/MRA.00169-19.

31.

A Case Report of Autosomal Dominant Polycystic Kidney Disease Under Peritoneal Dialysis With Cyst Infection and Culture-Positive Peritoneal Fluid.

Yasuda I, Hasegawa K, Tokuyama H, Washida N, Shinozuka K, Yasuda M, Ryuzaki M, Urai H, Wakino S, Itoh H.

Clin Med Insights Case Rep. 2019 Apr 29;12:1179547619846860. doi: 10.1177/1179547619846860. eCollection 2019.

32.

Influence of antihypertensive drugs in the subtype diagnosis of primary aldosteronism by adrenal venous sampling.

Nagasawa M, Yamamoto K, Rakugi H, Takeda M, Akasaka H, Umakoshi H, Tsuiki M, Takeda Y, Kurihara I, Itoh H, Ichijo T, Katabami T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Ogo A, Okamura S, Miyauchi S, Yanase T, Suzuki T, Kawamura T, Naruse M; JPAS Study Group.

J Hypertens. 2019 Jul;37(7):1493-1499. doi: 10.1097/HJH.0000000000002047.

PMID:
31033727
33.

High Prevalence of Diabetes in Patients With Primary Aldosteronism (PA) Associated With Subclinical Hypercortisolism and Prediabetes More Prevalent in Bilateral Than Unilateral PA: A Large, Multicenter Cohort Study in Japan.

Akehi Y, Yanase T, Motonaga R, Umakoshi H, Tsuiki M, Takeda Y, Yoneda T, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ashida K, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Hashimoto S, Yamada M, Yoshikawa Y, Kai T, Suzuki T, Kawamura T, Naruse M; Japan Primary Aldosteronism Study Group.

Diabetes Care. 2019 May;42(5):938-945. doi: 10.2337/dc18-1293.

PMID:
31010944
34.

Microscopic heat pulses activate cardiac thin filaments.

Ishii S, Oyama K, Arai T, Itoh H, Shintani SA, Suzuki M, Kobirumaki-Shimozawa F, Terui T, Fukuda N, Ishiwata S.

J Gen Physiol. 2019 Jun 3;151(6):860-869. doi: 10.1085/jgp.201812243. Epub 2019 Apr 22.

PMID:
31010810
35.

MicroRNA-204-5p: A novel candidate urinary biomarker of Xp11.2 translocation renal cell carcinoma.

Kurahashi R, Kadomatsu T, Baba M, Hara C, Itoh H, Miyata K, Endo M, Morinaga J, Terada K, Araki K, Eto M, Schmidt LS, Kamba T, Linehan WM, Oike Y.

Cancer Sci. 2019 Jun;110(6):1897-1908. doi: 10.1111/cas.14026. Epub 2019 May 24.

36.
37.

Serum S100A8/A9 as a Potentially Sensitive Biomarker for Inflammatory Bowel Disease.

Okada K, Okabe M, Kimura Y, Itoh H, Ikemoto M.

Lab Med. 2019 Apr 17. pii: lmz003. doi: 10.1093/labmed/lmz003. [Epub ahead of print]

PMID:
30994906
38.

JSH Statement: Asahikawa declaration in promotion of diversity by the Japanese society of hypertension-the JSH Asahikawa declaration.

Nakamura S, Hasebe N, Yatabe M, Kishi T, Ishida M, Ichihara A, Node K, Ishimitsu T, Itoh H, Ito M, Ohishi M, Ohkubo T, Kai H, Kashihara N, Kario K, Saitoh S, Tsuchihashi T, Nishiyama A, Higaki J, Miura K, Rakugi H, Kawano Y, Tamura K, Yatabe T, Ohya Y, Ito S.

Hypertens Res. 2019 Apr 8. doi: 10.1038/s41440-019-0261-3. [Epub ahead of print] No abstract available.

PMID:
30962519
39.

Role of anemia and proteinuria in the development of subsequent renal function deterioration in a general population with preserved glomerular filtration rate: a community-based cohort study.

Kiriyama H, Kaneko H, Itoh H, Yoshida Y, Nakanishi K, Mizuno Y, Daimon M, Morita H, Yatomi Y, Komuro I.

J Nephrol. 2019 Apr 6. doi: 10.1007/s40620-019-00605-2. [Epub ahead of print]

PMID:
30955155
40.

Comprehensive Structure-Activity Relationship Studies of Macrocyclic Natural Products Enabled by Their Total Syntheses.

Itoh H, Inoue M.

Chem Rev. 2019 Apr 4. doi: 10.1021/acs.chemrev.9b00063. [Epub ahead of print]

PMID:
30945851
41.

Role of Nampt-Sirt6 Axis in Renal Proximal Tubules in Extracellular Matrix Deposition in Diabetic Nephropathy.

Muraoka H, Hasegawa K, Sakamaki Y, Minakuchi H, Kawaguchi T, Yasuda I, Kanda T, Tokuyama H, Wakino S, Itoh H.

Cell Rep. 2019 Apr 2;27(1):199-212.e5. doi: 10.1016/j.celrep.2019.03.024.

42.

Efficacy and safety of switching to insulin glargine 300 U/mL from 100 U/mL in Japanese patients with type 2 diabetes: A 12-month retrospective analysis.

Sugiyama K, Meguro S, Saisho Y, Irie J, Tanaka M, Itoh H.

Heliyon. 2019 Feb 21;5(2):e01257. doi: 10.1016/j.heliyon.2019.e01257. eCollection 2019 Feb.

43.

Progesterone receptor expression in proliferating cancer cells of hormone-receptor-positive breast cancer.

Ueno T, Saji S, Chiba T, Kamma H, Isaka H, Itoh H, Imi K, Miyamoto K, Tada M, Sasano H, Toi M, Imoto S.

Tumour Biol. 2018 Nov;40(10):1010428318811025. doi: 10.1177/1010428318811025.

PMID:
30841783
44.

Oncoprotective Effects of Short-Chain Fatty Acids on Uterine Cervical Neoplasia.

Matsuya-Ogawa M, Shibata T, Itoh H, Murakami H, Yaguchi C, Sugihara K, Kanayama N.

Nutr Cancer. 2019;71(2):312-319. doi: 10.1080/01635581.2019.1578388. Epub 2019 Mar 5.

PMID:
30836015
45.

Factors involved in phenoconversion of CYP3A using 4β-hydroxycholesterol in stable kidney transplant recipients.

Suzuki Y, Muraya N, Fujioka T, Sato F, Tanaka R, Matsumoto K, Sato Y, Ohno K, Mimata H, Kishino S, Itoh H.

Pharmacol Rep. 2019 Apr;71(2):276-281. doi: 10.1016/j.pharep.2018.12.007. Epub 2018 Dec 15.

PMID:
30826567
46.

β-hydroxybutyrate attenuates renal ischemia-reperfusion injury through its anti-pyroptotic effects.

Tajima T, Yoshifuji A, Matsui A, Itoh T, Uchiyama K, Kanda T, Tokuyama H, Wakino S, Itoh H.

Kidney Int. 2019 May;95(5):1120-1137. doi: 10.1016/j.kint.2018.11.034. Epub 2019 Feb 28.

PMID:
30826015
47.

Search for transcription factors affecting productivity of the polyketide FR901512 in filamentous fungal sp. No. 14919 and identification of Drf1, a novel negative regulator of the biosynthetic gene cluster.

Itoh H, Miura A, Takeda I, Matsui M, Tamano K, Machida M, Shibata T.

Biosci Biotechnol Biochem. 2019 Jun;83(6):1163-1170. doi: 10.1080/09168451.2019.1584519. Epub 2019 Mar 1.

PMID:
30821612
48.

Recovery of OATP1B Activity after Living Kidney Transplantation in Patients with End-Stage Renal Disease.

Suzuki Y, Ono H, Tanaka R, Sato F, Sato Y, Ohno K, Mimata H, Itoh H.

Pharm Res. 2019 Feb 26;36(4):59. doi: 10.1007/s11095-019-2593-8.

PMID:
30809779
49.

Usefulness of hemoglobin A1c and glycated albumin measurements for insulinoma screening: an observational case-control study.

Torimoto K, Okada Y, Tanaka Y, Matsuoka A, Hirota Y, Ogawa W, Saisho Y, Kurihara I, Itoh H, Inada S, Koga M.

BMC Cancer. 2019 Feb 26;19(1):174. doi: 10.1186/s12885-019-5389-7.

50.

Home-based Aerobic Exercise and Resistance Training in Peritoneal Dialysis Patients: A Randomized Controlled Trial.

Uchiyama K, Washida N, Morimoto K, Muraoka K, Kasai T, Yamaki K, Miyashita K, Wakino S, Itoh H.

Sci Rep. 2019 Feb 22;9(1):2632. doi: 10.1038/s41598-019-39074-9.

Supplemental Content

Support Center